The overall risk of lung cancer has consistently been demonstrated to be greater in PWH than in people without HIV (PWOH) infection, with as high as a 3- to 4-fold increased risk, an effect independent of active combined antiretroviral treatment (cART), serum CD4+ T cell counts, or CD4+ T cell nadir values (4–6). The gene discussed is CD4; the disease is lung carcinoma.